Is Targeted Therapy — a Type of Chemotherapy?

It is a shorthand that has stuck. Both are medicines given in an oncology setting, sometimes on the same day, so the word 'chemo' is used loosely to mean any cancer treatment. Strictly, chemotherapy refers to drugs that work by killing rapidly dividing cells, while targeted therapy works by blocking a specific molecular pathway. If you are unsure what category your treatment falls into, ask your oncologist to explain the mechanism — it will also help you understand what side effects to expect.

The side effects are different rather than simply fewer. Chemotherapy commonly causes hair loss, nausea, mouth sores, and low blood counts because it affects all rapidly dividing cells. Targeted therapy more often causes skin rash, diarrhoea, fatigue, or liver enzyme changes, depending on the pathway it targets. Neither is side-effect-free. The profile that matters is the one for the specific treatment you are being offered — ask your oncologist what to watch for and which side effects need a same-day call.

Yes. Before targeted therapy can be prescribed, your tumour tissue is tested for the specific mutation or marker the drug is designed to block. Without that marker, the drug has no target to work on. The test is usually done on the biopsy sample you have already had, and results typically take one to two weeks. Chemotherapy does not require this kind of pre-treatment biomarker testing.

For some cancer types, yes — a combination is part of the standard recommended approach, not an experimental one. Whether it applies to your situation depends on your cancer type, stage, biomarker results, and general fitness. If your oncologist is recommending a combination, ask what each component is expected to do and what additional side effects the combination may bring compared with either treatment alone.

Some targeted therapies are oral tablets or capsules taken at home; others are given as an intravenous infusion in a day-care setting — it depends on the specific drug. The oral option is often easier in terms of travel and time, but it comes with the responsibility of taking it exactly as directed. Missed doses, food interactions, and drug interactions matter more with oral cancer medicines than people expect. Follow your oncologist's and pharmacist's instructions precisely.

Possibly, depending on your cancer type and what options remain at that point. Cancers can develop resistance to targeted therapy over time, which is one reason your team monitors your response regularly. When that happens, your oncologist will review the current evidence for your cancer type — which may include chemotherapy, a different targeted agent, immunotherapy, or a clinical trial. The right next step depends on your individual situation.

In general, targeted therapies are significantly more expensive than conventional chemotherapy, though costs vary widely depending on the specific drug, the regimen, and how long treatment continues. Some targeted therapies have become more affordable as generic versions have become available, and some are covered under government schemes in India. Any figure you are given is indicative — costs change. Ask the treatment team about expected cost before you commit, and ask whether any patient-assistance programmes apply to your situation.

Most targeted therapies do not cause the significant hair loss that chemotherapy does, because they do not work by attacking all rapidly dividing cells. Some can cause changes in hair texture or mild thinning, depending on the pathway they target. The specific side effects depend on the drug you are receiving. Your oncologist will tell you what to expect from your particular treatment before you start.